Drug Combo Approved for First-Line Treatment of Mesothelioma

MONDAY, Oct. 5, 2020 — On Friday, the U.S. Food and Drug Administration announced the approval of a drug combination for first-line treatment of unresectable malignant pleural mesothelioma (MPM) — the first drug regimen to be approved for…
Source: Topamax